A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants

Study Identifier
M24-966
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Recruitment Complete
Sign up for trial alerts

Study Details

Medical Condition
  • Healthy Volunteer
  • Study Drug
  • ABBV-932
  • Itraconazole
  • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 65 Years

    Protocol Summary

    This study will assess the adverse events and how oral ABBV-932 moves through the body when given with oral Itraconazole in healthy Adults participants.

    Study Locations

    Location
    Status
    Location
    Acpru /Id# 276951
    Grayslake, Illinois, United States, 60030
    Status
    Not applicable